Prescription drug denials are among the most common insurance denials, and they're increasing as plans add more medications to their prior authorization lists. Whether your medication is non-formulary, requires prior authorization, has hit a quantity limit, or requires step therapy, you have specific legal rights and effective appeal strategies available.

Understanding Your Drug Formulary

Health insurance formularies (drug lists) classify covered medications into tiers. Lower tiers are cheaper for patients; higher tiers cost more. Drugs on higher tiers or not on the formulary may require prior authorization, step therapy, or both. Under ACA §1302(b) and 45 CFR §156.122, Marketplace plans must cover at least one drug in every U.S. Pharmacopeia category and class, and must provide an exception process for non-formulary medications.

Formulary Exceptions: Your Right to Non-Formulary Coverage

A formulary exception allows coverage of a non-formulary drug at formulary cost-sharing when the formulary drug is not medically appropriate for you. Under 45 CFR §156.122, ACA-compliant plans must have this process. You can request an exception when:

How to File a Formulary Exception Request

  1. Call your insurer's pharmacy prior authorization line
  2. Your prescribing physician must submit documentation supporting the exception
  3. The physician's statement should include: diagnosis, why the formulary drug is not appropriate, clinical evidence supporting the requested drug, and the expected duration of treatment
  4. The insurer must decide within 72 hours (standard) or 24 hours (expedited/urgent)
  5. If denied, file a formal internal appeal with the same documentation

Medicare Part D Drug Appeals

Medicare Part D plans have a structured appeal process under 42 CFR §423.562-638:

  1. Coverage determination: Request coverage of the drug from your Part D plan. Physician must provide supporting statement. Decision: 72 hours standard / 24 hours expedited.
  2. Formulary exception: Request a formulary or tier exception for non-formulary drugs. Same 72/24-hour timeline.
  3. Redetermination: Internal appeal to the plan. Decision: 7 days standard / 72 hours expedited.
  4. IRE reconsideration: Independent review entity review. Decision: 7 days.
  5. ALJ hearing, MAC, Federal Court: Same as other Medicare appeals.

Prior Authorization for Specialty Drugs

Specialty medications — particularly biologics used for conditions like rheumatoid arthritis, psoriasis, Crohn's disease, multiple sclerosis, and cancer — are almost universally subject to prior authorization. For specialty drug PA, the key is a comprehensive physician letter that includes: the diagnosis with ICD-10 codes; the clinical reason the specific biologic is required (often disease severity, biomarkers, or genetic factors); all prior treatments tried with clinical outcomes; and the expected treatment duration and goals.

Quantity Limit Denials

Plans may limit the quantity of medication dispensed per month. Quantity limits can be challenged when the prescribed quantity is clinically appropriate and the plan's limit is insufficient. Document why the standard quantity does not meet your clinical needs. For medications with dosing that varies with clinical response (e.g., certain biologics injected less frequently when disease is controlled), request appropriate quantity for your prescribed dosing schedule.

Manufacturer Patient Assistance Programs

While pursuing your appeal, also contact the drug manufacturer's patient assistance program. Most major pharmaceutical companies offer free or reduced-cost medication programs for patients who cannot afford their medications. These programs can provide a bridge supply while your appeal proceeds. Search "[drug name] patient assistance program" or visit needymeds.org for a comprehensive database.